Bivalirudin in Late PCI for Oatients With STEMI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

Also called NCT04185077

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04185077
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04185077. Randomized; no masking; primary purpose treatment. Start 2019-11-30 (anticipated); primary completion 2020-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bivalirudin in Late PCI for Oatients With STEMI
Acronym
BETTER
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Heparin
Lead sponsor
Second Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct04185077
Content hash
41bd5b809a1f69c500cffad17fb6b53a6d67521cd08da033f923389453839333